Back to Search
TOMISLAV DRAGOVICH, MD, PHD
MD, PHD
Medical Oncology Physician
NPI: 1518979715IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME166799(FL)28383(AZ)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME166799(FL)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
ME166799(FL)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1988
Research & Publications (13)
Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept.
PMID 19636422·J Oncol·2009
8-other
Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation.
PMID 18469443·JOP·2008
5-case
Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.
PMID 18467723·J Clin Oncol·2008
3-trial
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial.
PMID 18391600·Am J Clin Oncol·2008
3-trial
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
PMID 17661038·Cancer Chemother Pharmacol·2008
3-trial
The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.
PMID 17545547·Clin Cancer Res·2007
8-other
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.
PMID 17404093·Clin Cancer Res·2007
3-trial
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.
PMID 17149608·Cancer Chemother Pharmacol·2007
3-trial
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
PMID 17050876·J Clin Oncol·2006
3-trial
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
PMID 16847673·Cancer Chemother Pharmacol·2006
3-trial
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.
PMID 16459166·J Lab Clin Med·2006
3-trial
Stability of phosphoprotein as a biological marker of tumor signaling.
PMID 15958615·Clin Cancer Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1301 PALM AVE STE 700
JACKSONVILLE, FL 32207 - Phone
- (904) 202-7300
Quick Facts
- NPI
- 1518979715
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 38
- Publications
- 13
Are you this provider?
Claim Your Profile